Brief: Rhythm Biosciences Acquires Genetype Genetic Risk Assessment Business
23/12/2024 01:15
Dec 23 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* RHY ACQUIRES GENETYPE GENETIC RISK ASSESSMENT BUSINESS
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt